Angiogenic and Fibrogenic Dual-effect of Gremlin1 on Proliferative Diabetic Retinopathy
International Journal of Biological Sciences · 2024 · 20 (3) · 897-915
DOI: 10.7150/ijbs.85735 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Xinjing Wu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Retinopathy, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Ocular angiogenic diseases, such as proliferative diabetic retinopathy (PDR), are often characterized by pathological new vessels and fibrosis formation. Anti-vascular endothelial growth factor (VEGF) therapy, despite of its efficiency to inhibit new vessels, has limitations, including drug resistance and retinal fibrosis. Here, we identified that Gremlin1, a novel angiogenesis and fibrosis inducer, was secreted from Müller glial cells, and its expression increased in the vitreous fluid from patients with PDR. Mechanistically, Gremlin1 triggered angiogenesis by promoting endothelial-mesenchymal transition via the EGFR/RhoA/ROCK pathway. In addition, Gremlin1 activated microglia to present profibrotic and fibrogenic properties. Further, anti-Gremlin1 antibody inhibited ocular angiogenesis and microglia fibrosis in mouse models. Collectively, Gremlin1 could be a potential therapeutic target in the treatment of ocular angiogenic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
- Department of Ophthalmology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian 223800, China.
- Department of Ophthalmology, People's Hospital of Yangzhong City, Yangzhong 212200, China.
- Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Zitieren
APA
Wu, X., Qin, B., Cheng, R., Zhou, R., Wang, X., Zhang, Z., Mao, X., Xie, Z., Chen, M., Jiang, L., Xie, P., Ji, J., Zhang, W., Yuan, S., Hu, Z., & Liu, Q. (2024). Angiogenic and Fibrogenic Dual-effect of Gremlin1 on Proliferative Diabetic Retinopathy. International Journal of Biological Sciences, 20(3), 897-915. https://doi.org/10.7150/ijbs.85735
Vancouver
Wu X, Qin B, Cheng R, Zhou R, Wang X, Zhang Z, et al. Angiogenic and Fibrogenic Dual-effect of Gremlin1 on Proliferative Diabetic Retinopathy. International Journal of Biological Sciences. 2024;20(3):897-915. doi:10.7150/ijbs.85735
BibTeX
@article{Wu2024,
author = {Wu, Xinjing and Qin, Bing and Cheng, Ruiwen and Zhou, Ru and Wang, Xingxing and Zhang, Zhengyu and Mao, Xiying and Xie, Zhan and Chen, Mingkang and Jiang, Lin and Xie, Ping and Ji, Jiangdong and Zhang, Weiwei and Yuan, Songtao and Hu, Zizhong and Liu, Qinghuai},
title = {Angiogenic and Fibrogenic Dual-effect of Gremlin1 on Proliferative Diabetic Retinopathy},
journal = {International Journal of Biological Sciences},
year = {2024},
volume = {20},
number = {3},
pages = {897--915},
doi = {10.7150/ijbs.85735}
}
EUVIMED